Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT02571894
Eligibility Criteria:
Inclusion Criteria:
* Women with newly diagnosed breast cancer who are eligible to receive neo-adjuvant or adjuvant chemotherapy, with or without trastuzumab, according to the guidelines for breast cancer.
* Written informed consent must be given.
Exclusion Criteria:
* A history of heart disease; ischemic heart disease, arrhythmias, heart failure, and valve diseases.
* Previously received oncological treatment for any malignancy.
* Other disease or conditions that complicates or precludes the patient from following the study protocol.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02571894
Study Brief:
Protocol Section:
NCT02571894